By maintaining a high level of vigilance and prioritizing patient education, it is possible to minimize risks and maximize the therapeutic benefits of these medications, ensuring optimal outcomes for patients navigating the complexities of treating diabetes, obesity, depression, and anxiety concurrently
Many patients begin to see improvements in cravings and energy levels within the first few weeks, leading to steady and noticeable weight loss
BMI requirements for GLP-1 medications are based on obesity treatment guidelines, FDA-approved indications, and clinical trials evaluating safety and effectiveness
Adam Kautzner, president of Express Scripts, told Fierce Healthcare that GLP-1s are currently the No
By preserving beta-cell function through the incretin system and reducing insulin resistance through metformin, researchers are evaluating if this combination can delay the need for insulin therapy longer than other oral agents
By day 3 to 5 post-injection, for most people, side effects have settled and appetite is suppressed but manageable